HIN 0.00% $2.37 heartware international, inc

Bridge to Transplant is complete - Outcome due Q4Destination...

  1. 228 Posts.
    Bridge to Transplant is complete - Outcome due Q4

    Destination Therapy - Trial Completion possibly end of Q4 - Approval end 2012
 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.